Severe Acute Respiratory Syndrome

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus (SARS-CoV). SARS was first reported in Asia in February 2003. Over the next few months, the illness spread to more than two dozen countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained.

SARS or Severe Acute Respiratory Syndrome is a viral respiratory illness caused by a coronavirus - the SARS associated coronavirus (SARS-CoV) - which can be life-threatening.

How SARS is Spread

SARS, Treatment, Control and Tests

SARS: Tips for Travellers

Does COVID-19 affect heart rate variability after recovery?

Researchers determine the impact of mild COVID-19 on heart rate variability.

31 Mar 2025

COVID-19 vaccines may cut risk of long COVID

Full COVID-19 vaccination may reduce post-COVID-19 condition risk by 27%, though more research is needed, especially for children and immunocompromised groups.

26 Mar 2025

How your diet and probiotics can improve vaccine effectiveness

Researchers uncover how probiotics and diet shape the gut microbiome to boost vaccine efficacy, offering new avenues for precision immunization.

23 Mar 2025

Scientists reveal how Epstein-Barr virus reactivation triggers MIS-C in children

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver of multisystem inflammatory syndrome in children (MIS-C) following COVID-19. Blocking TGFβ may offer a potential new treatment for this life-threatening condition.

13 Mar 2025

COVID-19 hospitalization linked to long-term organ damage and mortality

Researchers determine the risk of long-term health complications following recovery from COVID-19.

7 Mar 2025

Air sampling detects 70–90% of poultry viruses and reveals 50 more hidden threats

Researchers found that environmental sampling in live-bird markets detects 70–90% of poultry viruses, often outperforming traditional swab methods, and identified 50 additional viruses, some from non-avian sources.

26 Feb 2025

Lasting impact of long COVID and the protective benefits of vaccination

Researchers explore the mental and physical health outcomes in patients with long COVID.

19 Feb 2025

The growing list of human viruses: Are we prepared for the next outbreak?

Researchers review the ever-growing list of human viruses, examining their diversity, transmission pathways, and the urgent need for prevention and global surveillance.

12 Feb 2025

Natural immunity to SARS-CoV-2 weakened significantly after Omicron’s emergence

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.

6 Feb 2025

COVID-19 speeds up artery plaque growth, raising heart disease risk

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk plaques, even in non-hospitalized individuals.

5 Feb 2025

SARS-CoV-2 infection linked to rapid plaque growth in coronary arteries

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular events.

4 Feb 2025

In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, resulting in the coronavirus disease 2019 (COVID-19) pandemic.

4 Feb 2025